Observations placeholder
Pletal
Identifier
015659
Type of Spiritual Experience
Background
A description of the experience
Cilostazol /sɨˈlɒstəzɒl/ is a quinolinone-derivative medication used in the alleviation of the symptom of intermittent claudication in individuals with peripheral vascular disease. It is manufactured by Otsuka Pharmaceutical Co. under the trade name Pletal.
Although drugs similar to cilostazol have increased the risk of death in patients with congestive heart failure, studies of significant size have not addressed people without the disease.
Cilostazol is a phosphodiesterase inhibitor with therapeutic focus on cyclic adenosine monophosphate (cAMP). It inhibits platelet aggregation and is a direct arterial vasodilator. Its main effects are dilation of the arteries supplying blood to the legs and decreasing platelet coagulation.
On Mar, 27, 2015: 5,360 people reported to have side effects when taking Pletal. Among them, 28 people (0.52%) have Hallucination.
Time on Pletal when people have Hallucination :
< 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
Hallucination | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Gender of people who have Hallucination when taking Pletal :
Female | Male | |
Hallucination | 58.62% | 41.38% |
Age of people who have Hallucination when taking Pletal :
0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
Hallucination | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 3.70% | 11.11% | 85.19% |
On Dec, 25, 2016 5,726 people reported to have side effects when taking Pletal.
Among them, 121 people (2.11%) have Death